Should We Be Treating Affective Symptoms, Like Anxiety and Depression Which May Be Related to LUTD in Patients With OAB? ICI-RS 2024
- PMID: 39822015
- PMCID: PMC11920932
- DOI: 10.1002/nau.25662
Should We Be Treating Affective Symptoms, Like Anxiety and Depression Which May Be Related to LUTD in Patients With OAB? ICI-RS 2024
Abstract
Aims: To discuss the role of screening and treatment of affective symptoms, like anxiety and depression in patients with LUTD. A review of the literature regarding the bidirectional association and multidisciplinary approaches integrating psychometric assessments with personalized treatment plans to improve diagnostic accuracy and therapeutic outcomes of LUTD.
Methods: This review summarizes discussions and a narrative review of (recent) literature during an International Consultation on Incontinence-Research Society 2024 research proposal with respect to the role of screening for anxiety and depression, effect of mental health symptoms on treatment outcomes and future implications.
Results: Consensus recognized the importance to incorporate attention to anxiety and depression in relation to LUTD. The awareness of this association can lead to better outcomes. Future research projects are proposed to evaluate the bidirectional relationship.
Conclusion: The relationship between affective symptoms and LUTD underscores the need for integrated treatment approaches that address both psychological and urological dimensions. Further research is required to identify specific patient subgroups that would benefit most from these interventions, to develop standardized screening tools, and to refine treatment protocols. Multidisciplinary care, incorporating psychological assessment and personalized treatment strategies, could enhance outcomes for LUTD patients.
© 2025 The Author(s). Neurourology and Urodynamics published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Are psychological comorbidities important in the aetiology of lower urinary tract dysfunction-ICI-RS 2018?Neurourol Urodyn. 2019 Dec;38 Suppl 5:S8-S17. doi: 10.1002/nau.24016. Epub 2019 May 6. Neurourol Urodyn. 2019. PMID: 31059602 Review.
-
Affective symptoms and quality of life in patients with voiding or storage dysfunction: Results before and after sacral neuromodulation: A prospective follow-up study.Neurourol Urodyn. 2018 Jun;37(5):1801-1808. doi: 10.1002/nau.23527. Epub 2018 Mar 5. Neurourol Urodyn. 2018. PMID: 29504634
-
Do We Need to Re-Focus on Functional Female Urethral Disorders in Lower Urinary Tract Dysfunction? ICI-RS 2024.Neurourol Urodyn. 2025 Mar;44(3):558-567. doi: 10.1002/nau.25633. Epub 2024 Nov 28. Neurourol Urodyn. 2025. PMID: 39610086 Review.
-
Screening for depression and anxiety in patients with storage or voiding dysfunction: A retrospective cohort study predicting outcome of sacral neuromodulation.Neurourol Urodyn. 2016 Nov;35(8):1011-1016. doi: 10.1002/nau.22871. Epub 2015 Sep 9. Neurourol Urodyn. 2016. PMID: 26351817
-
How does lower urinary tract dysfunction (LUTD) affect sexual function in men and women? ICI-RS 2015-Part 2.Neurourol Urodyn. 2017 Apr;36(4):869-875. doi: 10.1002/nau.23088. Neurourol Urodyn. 2017. PMID: 28444704 Review.
Cited by
-
Depression mediates the association between lipid accumulation products and overactive bladder.Sci Rep. 2025 Aug 6;15(1):28797. doi: 10.1038/s41598-025-11401-3. Sci Rep. 2025. PMID: 40770007 Free PMC article.
References
-
- Vrijens D., Berghmans B., Nieman F., van Os J., van Koeveringe G., and Leue C., “Prevalence of Anxiety and Depressive Symptoms and Their Association With Pelvic Floor Dysfunctions‐A Cross Sectional Cohort Study at a Pelvic Care Centre,” Neurourology and Urodynamics 36, no. 7 (2017): 1816–1823, 10.1002/nau.23186. - DOI - PubMed
-
- Hughes F. M., Odom M. R., Cervantes A., Livingston A. J., and Purves J. T., “Why Are Some People With Lower Urinary Tract Symptoms (LUTS) Depressed? New Evidence That Peripheral Inflammation in the Bladder Causes Central Inflammation and Mood Disorders,” International Journal of Molecular Sciences 24, no. 3 (2023): 2821, 10.3390/ijms24032821. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical